ロード中...
Caffeine attenuates lipopolysaccharide-induced neuroinflammation
Caffeine is an antagonist at A1 and A2A adenosine receptors and epidemiological evidence suggests that caffeine consumption reduces the risk of Alzheimer's and Parkinson's diseases. Neuroinflammation plays a role in the etiology of these diseases and caffeine may provide protection through...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2010
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2905864/ https://ncbi.nlm.nih.gov/pubmed/20541589 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neulet.2010.06.013 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|